The aim of this systematic review was to investigate this bidirectional relationship mediated by serum BDNF levels and to explain whether and to what extent altered serum BDNF levels might serve as biomarkers for predicting the development of depression and CVD in patients diagnosed with CVD and patients diagnosed with depression, respectively. This evidence concerns the gene BDNF and major depressive disorder.